Gujarat Inject (Kerala) logo

Gujarat Inject (Kerala) share news, announcements and annual reports

BSE: 524238Pharmaceuticals & BiotechnologySmall Cap

Gujarat Inject (Kerala) Ltd. · Face value ₹1 · Listed Oct 1992
Last close ₹11.16down ₹0.06 (0.53%)

Share price at the BSE close on 30 Oct 2026. Previous close ₹11.22.

30 Oct: open ₹11.29, high ₹11.54, low ₹10.77

52-week range of traded prices to 30 Oct 2026
₹2.06Low, 30 Oct 2025₹14.30High, 9 Jul 2026
Market cap
₹163 Cr2,790th largest listed
P/E
54.64
P/B
13.82
Dividend yield
Nonein the last 12 months
ROE
27.4%
ROCE
32.9%
Debt to equity
0.00
Volume, BSE
1,44,603

Gujarat Inject (Kerala) share news and announcements

407 announcements, routine notices left out, newest first. Page 5 of 9.

  1. Jul 2022

  2. May 2022

  3. Apr 2022

    • 21 Apr · Statement Of Investor Complaints For The Quarter Ended March 2022

      No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
  4. Feb 2022

  5. Nov 2021

  6. Oct 2021

  7. Sep 2021

  8. Aug 2021

  9. Jul 2021

  10. Jun 2021

  11. May 2021

    • 10 May · Shareholding for the Period Ended December 31, 2020

      Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click ....
    • 10 May · Shareholding for the Period Ended March 31, 2021

      Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click ....
  12. Apr 2021

    • 14 Apr · Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended On 31St March, 2021.

    • 10 Apr · Submission Of Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015 For The Half Year Ended On 31St March, 2021.

    • 7 Apr · Statement Of Investor Complaints For The Quarter Ended March 2021

      No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
  13. Mar 2021